Cargando…
The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay
BACKGROUND: The diagnosis of von Willebrand disease is complex due to the heterogeneity of the disease. About eighty percent of von Willebrand disease patients are diagnosed with a quantitative defect of von Willebrand factor (VWF) where fifty percent is due to an increased clearance of von Willebra...
Autores principales: | Meiring, S. M., Setlai, B. D. P., Theron, C., Bragg, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994315/ https://www.ncbi.nlm.nih.gov/pubmed/29992156 http://dx.doi.org/10.1155/2018/6232091 |
Ejemplares similares
-
Elevated Plasma Von Willebrand Factor and Propeptide Levels in Malawian Children with Malaria
por: Phiri, Happy T., et al.
Publicado: (2011) -
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
por: Scheja, Agneta, et al.
Publicado: (2001) -
von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups
por: Marianor, Mahat, et al.
Publicado: (2015) -
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
por: Pagliari, Maria Teresa, et al.
Publicado: (2022) -
The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients
por: Pagliari, Maria Teresa, et al.
Publicado: (2022)